Antidepressant use in gastroenterology: overcoming hurdles

Daniel Keszthelyi

doi:10.1111/nmo.13982

Antidepressant use in gastroenterology: overcoming hurdles

Daniel Keszthelyi^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

107 Downloads (Pure)

Original language	English
Article number	e13982
Number of pages	1
Journal	Neurogastroenterology and Motility
Volume	32
Issue number	10
Early online date	15 Sept 2020
DOIs	https://doi.org/10.1111/nmo.13982
Publication status	Published - Oct 2020

Keywords

MANAGEMENT

Access to Document

10.1111/nmo.13982

Full text Final published version, 169 KBLicence: Taverne

Cite this

@article{5a9b661ec55f4b5e8786e8fb0aeb27d1,

title = "Antidepressant use in gastroenterology: overcoming hurdles",

keywords = "MANAGEMENT",

author = "Daniel Keszthelyi",

note = "Funding Information: The author has received research funding from Will Pharma, Grunenthal, and Allergan and has served on the advisory board for Bayer and Biocodex.",

year = "2020",

month = oct,

doi = "10.1111/nmo.13982",

language = "English",

volume = "32",

journal = "Neurogastroenterology and Motility",

issn = "1350-1925",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Antidepressant use in gastroenterology

T2 - overcoming hurdles

AU - Keszthelyi, Daniel

N1 - Funding Information: The author has received research funding from Will Pharma, Grunenthal, and Allergan and has served on the advisory board for Bayer and Biocodex.

PY - 2020/10

Y1 - 2020/10

KW - MANAGEMENT

U2 - 10.1111/nmo.13982

DO - 10.1111/nmo.13982

M3 - Comment/Letter to the editor

C2 - 32935408

SN - 1350-1925

VL - 32

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

IS - 10

M1 - e13982

ER -